J004-1320 Screening compound: 3-[1-(2-fluorobenzoyl)pyrrolidin-2-yl]-5-(propan-2-yl)-1,2-oxazole

J004-1320 Screening compound: 3-[1-(2-fluorobenzoyl)pyrrolidin-2-yl]-5-(propan-2-yl)-1,2-oxazole
J004-1320 Screening compound: 3-[1-(2-fluorobenzoyl)pyrrolidin-2-yl]-5-(propan-2-yl)-1,2-oxazole alternative view

Chemical Structure Depiction of ChemDiv screening compound J004-1320
3-[1-(2-fluorobenzoyl)pyrrolidin-2-yl]-5-(propan-2-yl)-1,2-oxazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J004-1320

Molecular Formula

C17H19FN2O2 (C17 H19 FN2 O2)

Compound Name

3-[1-(2-fluorobenzoyl)pyrrolidin-2-yl]-5-(propan-2-yl)-1,2-oxazole

IUPAC name

3-[1-(2-fluorobenzoyl)pyrrolidin-2-yl]-5-(propan-2-yl)-12-oxazole

SMILES

CC(C)c1cc(C(CCC2)N2C(c(cccc2)c2F)=O)no1

InChI

InChI=1S/C17H19FN2O2/c1-11(2)16-10-14(19-22-16)15-8-5-9-20(15)17(21)12-6-3-4-7-13(12)18/h3-4,6-7,10-11,15H,5,8-9H2,1-2H3/t15-/m0/s1

InChI Key

WXRHVMGDVZNODN-HNNXBMFYSA-N

MDL Number (MFCD)

MFCD18487981

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

302.35

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

3.388

Distribution Coefficient, logD

3.388

Water Solubility, LogSw

-3.81

Polar Surface Area

38.482

Acid Dissociation Constant (pKa)

24.20

Base Dissociation Constant (pKb)

-2.92

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

41.20

J004-1320 in Drug Discovery

Included in Screening Libraries

Hsp90-Targeted Library (11355 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Targets:
  • Proteases
Structure:
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with J004-1320 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound J004-1320?
Check Price and Availability of J004-1320, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of J004-1320 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for J004-1320
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for J004-1320
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of J004-1320 available by request